Umesh Masharani, M.B., M.D.
- Clinical Professor of Medicine
- Division of Endocrinology
- Department of Medicine
Contact Information
400 Parnassus Ave.
ACC 585, Box 1222
San Francisco, CA 94143
[email protected]
All Clinic Information
Education
Middlesex Medical School, London 1982
Biography
Dr. Masharani is a Clinical Professor of Endocrinology and Metabolism in the Department of Medicine, UCSF. He has an active clinical practice treating patients with diabetes and other endocrine disorders. . As a member of the UCSF Islet Transplant Group, Dr Masharani assists in managing diabetes of patients admitted to UCSF for islet transplantation evaluation.
Dr. Masharani is Co-Chair of the University of California, San Francisco Diabetes Teaching Center Annual Patient Symposium. Dr. Masharani is the author of Diabetes Demystified, a complete guide to understanding and managing diabetes.
Research Overview
Dr. Masharani is a Co-Investigator on a number of NIH funded diabetes studies at UCSF. His research includes studies evaluating the effect of chromium and alpha lipoic acid on insulin resistance, and anti-CD3 antibodies on new onset type 1 diabetes and multi-ethnic studies addressing the interactive relationships among disease management, glucose control and depression in patients with type 2 diabetes.
Research & Funding
- Chromium and Insulin ResistanceSponsor: NIH/NCCIHSponsor ID: R21AT002616Funding Period:Aug 2005-Jul 2010Principal Investigator
- PEDIATRIC CLINICAL RESEARCH CENTERSponsor: NIH/NCRRSponsor ID: M01RR001271Funding Period:Dec 1981-Mar 2007Co-Investigator
- BIOGENESIS, TOPOLOGY AND FUNCTION OF GRP 94Sponsor: NIH/NIGMSSponsor ID: F32GM015460Funding Period:Jan 1993-Jan 0001Principal Investigator
Clinical Trials
- Study ID: NCT00845156Start Date: Jan 2008Estimated Completion Date: Sep 2010Condition(s): Insulin Resistance
- Study ID: NCT00548782Start Date: Sep 2007Estimated Completion Date: Jan 0001Condition(s): Diabetes, Diabetes Type 2
- Study ID: NCT00505427Start Date: Mar 2006Estimated Completion Date: Jul 2010Condition(s): Insulin Resistance, Oxidative Stress, Polycystic Ovary Syndrome
- Study ID: NCT00846248Start Date: Jan 2006Estimated Completion Date: Jul 2011Condition(s): Insulin Resistance
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 83
- Tian T, Aaron RE, Yeung AM, Huang J, Drincic A, Seley JJ, Wallia A, Gilbert G, Spanakis EK, Masharani U, Faulds E, Hirsch IB, Dawood GE, Espinoza JC, Mendez CE, Kerr D, Klonoff DC. Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023. J Diabetes Sci Technol. 2023 09; 17(5):1392-1418. View in PubMed
- Niu I, Hsiao EC, Wustrack R, Wysolmerski JJ, Dann P, Masharani U. A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy. Calcif Tissue Int. 2023 08; 113(2):246-253. View in PubMed
- Wisel SA, Posselt AM, Szot GL, Nunez M, Santos-Parker K, Gardner JM, Worner G, Roll GR, Syed S, Kelly Y, Ward C, Tavakol M, Johnson K, Masharani U, Stock PG. A Multi-Modal Approach to Islet and Pancreas Transplantation With Calcineurin-Sparing Immunosuppression Maintains Long-Term Insulin Independence in Patients With Type I Diabetes. Transpl Int. 2023; 36:11367. View in PubMed
- Rodriguez-Valadez JM, Tahsin M, Fleischmann KE, Masharani U, Yeboah J, Park M, Li L, Weber E, Li Y, Berkalieva A, Max W, Hunink MGM, Ferket BS. Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression. Diabetes Care. 2023 06 01; 46(6):1300-1310. View in PubMed
- Quandt Z, Kim S, Villanueva-Meyer J, Coupe C, Young A, Kang JH, Yazdany J, Schmajuk G, Rush S, Ziv E, Perdigoto AL, Herold K, Lechner MG, Su MA, Tyrrell JB, Bluestone J, Anderson M, Masharani U. Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis. J Endocr Soc. 2023 Feb 09; 7(4):bvad012. View in PubMed
- View All Publications